Intervention not reported
Adverse events · HIV‐positive people
It is very uncertain whether the intervention changes adverse events (very low certainty).
1 finding from 1 review
Adverse events · people undergoing colonoscopy for the detection of polyps
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults with chronic wounds
It is very uncertain whether autologous platelet‐rich plasma changes adverse events compared with standard care with/without placebo (very low certainty).
1 finding from 1 review
Adverse events · RLS
Opioids may leads to higher adverse Events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · induction of remission in Crohn's disease
Ustekinumab showed no clear difference in adverse events compared with placebo (high certainty).
1 finding from 1 review
Adverse events · women with FPHL
Minoxidil 2% showed no clear difference in adverse events compared with minoxidil 5% (low certainty).
1 finding from 1 review
Adverse events · women with FPHL
Finasteride showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · women with FPHL
1 finding from 1 review
Adverse events · women with FPHL
Minoxidil showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · people with acute TBI secondary to head injury
1 finding from 1 review
Adverse events · patients with heart failure
1 finding from 1 review
Adverse events · chronic heart failure in Chagas cardiomyopathy patients
1 finding from 1 review
Adverse events · heart failure in patients with Chagas cardiomyopathy
It is very uncertain whether carvedilol changes adverse events compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
It is very uncertain whether high dose PEG changes adverse events compared with low dose PEG (very low certainty).
1 finding from 1 review
Adverse events · patients aged 0 to 18 years with a diagnosis of functional constipation
PEG showed no clear difference in adverse events compared with lactulose (moderate certainty).
1 finding from 1 review
Adverse events · pain treatment during intravenous cannulation
1 finding from 1 review
Adverse events · people with serious mental illness
1 finding from 1 review
Adverse events · malnourished or nutritionally at‐risk adults
1 finding from 1 review
Intervention not reported
Adverse events · People with asthma (mostly mild or moderate)
1 finding from 1 review
Adverse events · men and women with their first episode of genital herpes
1 finding from 1 review